Total Synthesis and Evaluation of Cytostatin, Its C10−C11 Diastereomers, and Additional Key Analogues:  Impact on PP2A Inhibition

Brian G. Lawhorn, Sobhana B. Boga, Scott E. Wolkenberg, David A. Colby, Carla-Maria Gauss, Mark R. Swingle, Lauren Amable, Richard E. Honkanen, and Dale L. Boger*
Contribution from the Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, and Department of Biochemistry and Molecular Biology, University of South Alabama College of Medicine, Mobile, Alabama 36688
J. Am. Chem. Soc., 2006, 128 (51), pp 16720–16732
DOI: 10.1021/ja066477d
Publication Date (Web): December 7, 2006
Copyright © 2006 American Chemical Society

Abstract

Abstract Image

The total synthesis of cytostatin, an antitumor agent belonging to the fostriecin family of natural products, is described in full detail. The convergent approach relied on a key epoxide-opening reaction to join the two stereotriad units and a single-step late-stage stereoselective installation of the sensitive (Z,Z,E)-triene through a β-chelation-controlled nucleophilic addition. The synthetic route provided rapid access to the C4−C6 stereoisomers of the cytostatin lactone, which were prepared and used to define the C4−C6 relative stereochemistry of the natural product. In addition to the natural product, each of the C10−C11 diastereomers of cytostatin was divergently prepared (11 steps from key convergence step) by this route and used to unequivocally confirm the relative and absolute stereochemistry of cytostatin. Each of the cytostatin diastereomers exhibited a reduced activity toward inhibition of PP2A (>100-fold), demonstrating the importance of the presence and stereochemistry of the C10-methyl and C11-hydroxy groups for potent PP2A inhibition. Extensions of the studies provided dephosphocytostatin, sulfocytostatin (a key analogue related to the natural product sultriecin), 11-deshydroxycytostatin, and an analogue lacking the entire C12−C18 (Z,Z,E)-triene segment, which were used to define the magnitude of the C9-phosphate (>4000-fold), C11-alcohol (250-fold), and triene (220-fold) contribution to PP2A inhibition. A model of cytostatin bound to the active site of PP2A is presented, compared to that of fostriecin, which is also presented in detail for the first time, and used to provide insights into the role of the key substituents. Notably, the α,β-unsaturated lactone of cytostatin, like that of fostriecin, is projected to serve as a key electrophile, providing a covalent adduct with Cys269 unique to PP2A, contributing to its potency (≥200-fold for fostriecin) and accounting for its selectivity.

Citing Articles

View all 17 citing articles

Citation data is made available by participants in CrossRef's Cited-by Linking service. For a more comprehensive list of citations to this article, users are encouraged to perform a search in SciFinder.

This article has been cited by 9 ACS Journal articles (5 most recent appear below).

Tools

SciFinder Links

SciFinder subscribers:  Click to sign in | Not a SciFinder subscriber? Learn more at www.cas.org

Explore by:


History

  • Published In Issue December 27, 2006
  • Received September 13, 2006

Recommend & Share

  • Share on ACS NetworkACS Network
  • Add to FacebookFacebook
  • Tweet ThisTweet This
  • Add to CiteULikeCiteULike
  • Add to NewsvineNewsvine
  • Digg ThisDigg This
  • Add to DeliciousDelicious

Related Content

Other ACS content by these authors: